Stephen J Hoffman is of ACELRX PHARMACEUTICALS INC. Currently has a direct ownership of 4,592 shares of ACRX, which is worth approximately $5,188. The most recent transaction as insider was on Jun 24, 2024, when has been sold 2,174 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.59K
0% 3M change
89.91% 12M change
Total Value Held $5,188

STEPHEN J HOFFMAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 24 2024
BUY
Grant, award, or other acquisition
-
2,174 Added 32.13%
4,592 Common Stock
Oct 10 2023
BUY
Grant, award, or other acquisition
-
581 Added 19.37%
2,418 Common Stock
Jul 15 2022
BUY
Grant, award, or other acquisition
-
15,500 Added 29.67%
36,750 Common Stock
Jun 17 2021
BUY
Grant, award, or other acquisition
-
10,000 Added 32.0%
21,250 Common Stock

Also insider at

DRNA
Dicerna Pharmaceuticals Inc
SJH

Stephen J Hoffman

Hayward, CA

Track Institutional and Insider Activities on ACRX

Follow ACELRX PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRX shares.

Notify only if

Insider Trading

Get notified when an Acelrx Pharmaceuticals Inc insider buys or sells ACRX shares.

Notify only if

News

Receive news related to ACELRX PHARMACEUTICALS INC

Track Activities on ACRX